Ocular Therapeutix™ To Report Fourth Quarter 2017 Financial Results
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report fourth quarter and full year ended December 31, 2017 financial results on Thursday, March 8, 2018. Following distribution of the earnings release via wire services, the Ocular Therapeutix management team will host a live conference